TPCW
SRTA

TD Private Client Wealth’s Strata Critical Medical Inc SRTA Stock Holding History

TD Private Client Wealth’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-121
Closed -$612 – 1647
2025
Q3 		$612 Buy
+121
New +$535 ﹤0.01% 1440

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

TD Private Client Wealth's SRTA Position: Q4 2025 in Review

TD Private Client Wealth sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 121 shares — an estimated $612 sold.

TD Private Client Wealth first reported a position in SRTA in Q3 2025 and held it in 1 quarter. The position peaked at $612 in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • TD Private Client Wealth reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • TD Private Client Wealth sold 121 Strata Critical Medical Inc shares in Q4 2025, an estimated $612.
  • TD Private Client Wealth first reported a position in Strata Critical Medical Inc in Q3 2025 and held it in 1 quarter.
  • TD Private Client Wealth's Strata Critical Medical Inc position peaked at $612 in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on TD Private Client Wealth's 13F filing for Q4 2025, filed 5 Feb 2026.